Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Cancer Med · 2020 · PMC6943086 · PMID 31702882

Europe PMC DOI

hedged sentence

0.3700

closest p · 7.4× alpha

0.3700

boldest claim

The sentences

did not reach statistical significanceP = .37not close (p > 0.1)

Cumulative incidence of moderate‐severe cGVHD was higher after grade 2 or ≥3 CRS relative to no CRS (7% vs 13% vs 0%), but did not reach statistical significance ( P = .37). 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.